Common Contracts
1 similar null contracts
Bridgewater, NJ and Toronto, ON- February 15, 2011 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research agreement and licensing option for vasculotide,...February 14th, 2011
The Fibrosis and Wound Repair unit is one of five Therapeutic Strategy Units created as part of sanofi- aventis’ new R&D model. Three of these units cover major pathophysiology areas where there is significant unmet medical need: immuno-inflammatory disorders, infectious disease and fibrosis and wound repair. The remaining two incorporate work in a challenging area of public health (the physiology of aging) and a high- potential geographic segment (Asia-Pacific region). The focus of the Therapeutic Strategy Units is to identify health solutions through pooling internal and external expertise and bring them to the clinic.
